Literature DB >> 22115042

MOCA is an integrator of the neuronal death signals that are activated by familial Alzheimer's disease-related mutants of amyloid β precursor protein and presenilins.

Nobuyuki Tachi1, Yuichi Hashimoto, Masaaki Matsuoka.   

Abstract

The death of cholinergic neurons in the cerebral cortex and certain subcortical regions is linked to irreversible dementia relevant to AD (Alzheimer's disease). Although multiple studies have shown that expression of a FAD (familial AD)-linked APP (amyloid β precursor protein) or a PS (presenilin) mutant, but not that of wild-type APP or PS, induced neuronal death by activating intracellular death signals, it remains to be addressed how these signals are interrelated and what the key molecule involved in this process is. In the present study, we show that the PS1-mediated (or possibly the PS2-mediated) signal is essential for the APP-mediated death in a γ-secretase-independent manner and vice versa. MOCA (modifier of cell adhesion), which was originally identified as being a PS- and Rac1-binding protein, is a common downstream constituent of these neuronal death signals. Detailed molecular analysis indicates that MOCA is a key molecule of the AD-relevant neuronal death signals that links the PS-mediated death signal with the APP-mediated death signal at a point between Rac1 [or Cdc42 (cell division cycle 42)] and ASK1 (apoptosis signal-regulating kinase 1).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22115042     DOI: 10.1042/BJ20100993

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  The role of UNC5C in Alzheimer's disease.

Authors:  Quan Li; Bai-Ling Wang; Fu-Rong Sun; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  The potential role of rho GTPases in Alzheimer's disease pathogenesis.

Authors:  Silvia Bolognin; Erika Lorenzetto; Giovanni Diana; Mario Buffelli
Journal:  Mol Neurobiol       Date:  2014-01-23       Impact factor: 5.590

3.  DOCK3-related neurodevelopmental syndrome: Biallelic intragenic deletion of DOCK3 in a boy with developmental delay and hypotonia.

Authors:  Aiko Iwata-Otsubo; Alyssa L Ritter; Brooke Weckselbatt; Nicole R Ryan; David Burgess; Laura K Conlin; Kosuke Izumi
Journal:  Am J Med Genet A       Date:  2017-11-12       Impact factor: 2.802

4.  MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Natássia M Vieira; Iris Eisenberg; Jamie L Marshall; Molly J Gasperini; Angela Lek; Jennifer A Myers; Elicia A Estrella; Peter B Kang; Frederic Shapiro; Fedik Rahimov; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

Review 5.  DOCKopathies: A systematic review of the clinical pathologies associated with human DOCK pathogenic variants.

Authors:  Adrienne Samani; Katherine G English; Michael A Lopez; Camille L Birch; Donna M Brown; Gurpreet Kaur; Elizabeth A Worthey; Matthew S Alexander
Journal:  Hum Mutat       Date:  2022-05-20       Impact factor: 4.700

6.  An Alzheimer Disease-linked Rare Mutation Potentiates Netrin Receptor Uncoordinated-5C-induced Signaling That Merges with Amyloid β Precursor Protein Signaling.

Authors:  Yuichi Hashimoto; Yuka Toyama; Shinya Kusakari; Mikiro Nawa; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2016-04-11       Impact factor: 5.157

7.  SH3-binding protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-Jun NH2-terminal kinase.

Authors:  Yuji Takeshita; Yuichi Hashimoto; Mikiro Nawa; Hiroyuki Uchino; Masaaki Matsuoka
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

Review 8.  Dock protein family in brain development and neurological disease.

Authors:  Lei Shi
Journal:  Commun Integr Biol       Date:  2013-11-13

9.  Zizimin and Dock guanine nucleotide exchange factors in cell function and disease.

Authors:  Nicholl K Pakes; Douwe M Veltman; Robin S B Williams
Journal:  Small GTPases       Date:  2012-12-17

Review 10.  The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases.

Authors:  Cristian A Droppelmann; Danae Campos-Melo; Kathryn Volkening; Michael J Strong
Journal:  Front Cell Neurosci       Date:  2014-09-10       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.